Daily News Watch

News Home Page

Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.

Rheonix to Automate FFPE Tissue Samples for Next Generation Sequencing

Rheonix Inc., a developer of fully automated molecular diagnostics solutions, has been granted patent 8,852,919 "Microfluidic Apparatus, Method, and Applications" for its automated molecular diagnostics system, the EncompassMD.  This recent patent will help researchers and clinicians analyze tissue samples preserved in paraffin more efficiently, at a lower cost and with higher processing throughput.The '919 patent automates a liquid-liquid extraction process that easily removes paraffin from ...

Posted on: October 21, 2014
NovoPath Announces a Standardized HL7 Interface with athenahealth

Committed to meeting a full range of anatomic pathology laboratory needs, NovoPath announces an interface to athenahealth for NovoPath's Anatomic Pathology Laboratory Information System (APLIS). athenahealth, a leading provider of cloud-based services and mobile tools for medical groups and health systems, combines award-winning software, network knowledge and back-office services to take on providers' most onerous work and keep them ahead of change.athenahealth joins NovoPath's growing roster of ...

Posted on: October 20, 2014
Claritas Genomics Launches Next Generation Sequencing Panel to Detect Genetic Causes of Nephrotic Syndrome in Children

Claritas Genomics, a clinical laboratory serving the DNA-based diagnostic testing needs of children's hospitals, announced the availability of a next-generation sequencing assay that investigates 28 genes that represent single-gene causes of pediatric steroid-resistant Nephrotic Syndrome. The assay was developed in collaboration with  a laboratory at Boston Children's Hospital that has been studying the underlying genetic causes of many types of pediatric kidney disorders for several decades.Patrice ...

Posted on: October 19, 2014
Study Shows Children Who Have Had Enterovirus Infection Are 48% More Likely To Have Type 1 Diabetes

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that children who have been infected with enterovirus are 48% more likely to have developed type 1 diabetes. The study is by Tsai Chung-Li, MD, China Medical University, Taiwan, and colleagues."Type 1 diabetes is considered to be caused by complex interaction between genetic susceptibility, the immune system, and environmental factors," say the authors. "Though the cue for genetic ...

Posted on: October 18, 2014
Beckman Coulter Receives FDA Clearance on Power Express High-Speed Automated Sample Processing System

Beckman Coulter has received FDA) 510(k) clearance on its Power Express high-speed automated sample processing system. Designed to meet the needs of the most demanding laboratories, the Power Express processes samples for all core disciplines - chemistry, immunoassay, hematology and coagulation. The Power Express provides the enhanced benefit of connected automation by combining Beckman Coulter's industry-leading AU clinical chemistry system; the UniCel DxI 800 immunoassay system for high-throughput ...

Posted on: October 17, 2014
Pa. Governor Corbett Signs Bill Expanding Newborn Screening Requirements

Gov.Tom Corbett signed House Bill 1654 into law at an event in the Capitol on Oct. 16, expanding newborn screening requirements to assist in early detection measures that will help to improve care for children diagnosed with certain rare disorders.Currently, Pennsylvania's birthing facilities test for 6 mandated conditions and 23 follow-up conditions - everything from cystic fibrosis to congenital heart disease.The new law will require physicians, hospitals and other institutions to add certain lysosomal ...

Posted on: October 16, 2014
CAP Guideline Receives ASCO Endorsement

CAP announced yesterday that the American Society of Clinical Oncology (ASCO) has endorsed the joint College of American Pathologists (CAP)/International Association for the Study of Lung Cancer (IASLC)/Association of Molecular Pathology (AMP) clinical practice guideline on molecular testing for selection of patients with lung cancer for therapies targeting epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK). The guideline defines which patients should be offered EGFR and ALK ...

Posted on: October 16, 2014
Luminex Receives FDA Clearance To Add New Clinical Targets And Additional Sample Type For Use With xTAG Gastrointestinal Pathogen Panel

Luminex Corporation has received  FDA clearance to add three new targets to its xTAG Gastrointestinal Pathogen Panel (GPP). The targets include Adenovirus 40/41, Entamoeba histolytica and Vibrio cholerae. In addition, FDA has now cleared xTAG GPP for use with specimens in Cary-Blair medium, a common transport medium for collection and preservation of microbiological specimens."xTAG GPP helps me quickly identify the causes of gastroenteritis by testing for viruses, bacteria and parasites in one test," ...

Posted on: October 15, 2014
Clinical Validation Study of Asserts Oncotype DX as Predictor of Near- and Long-term Outcomes in Racially Diverse Group of Prostate Cancer Patients

Genomic Health Inc. has announced strongly positive results from an additional independent clinical validation study of the Oncotype DX prostate cancer test, conducted in collaboration with the Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research (CPDR) supported by a multi-disciplinary team of investigators under a cooperative research and development agreement with USU. This new large study reconfirmed the biopsy-based test's Genomic Prostate Score (GPS) as a ...

Posted on: October 14, 2014
Abbott's RealTime High Risk HPV Test is Now Available in Europe for Primary Screening for Cervical Cancer

Abbott's DNA test for the detection of high-risk human papillomavirus (HR HPV) is now available in Europe as an important tool for first-line screening. The test is able to identify women at increased risk for development of cervical cancer or the presence of high-grade disease.The Abbott RealTime High Risk HPV test has been clinically validated in many significant studies conducted in European countries in recent years and the intended use has been expanded to include first-line primary ...

Posted on: October 13, 2014
New Application Note for TAP's ambr15 Micro Bioreactors Provides Tips on how to Maximize Data Collection

TAP Biosystems (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture and fermentation systems for life science applications, today announced the availability of a new technical note on managing sample volume for its ambr15 micro bioreactor system. This note will provide a guide for scientists to obtain critical data using easy-to-implement sampling regimes and analytical techniques, thus maximizing the capabilities of the ambr15 to make process development for ...

Posted on: October 12, 2014
Accelerate Diagnostics Supports President's Initiative to Combat Antibiotic-Resistant Bacteria

Accelerate Diagnostics Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, has commended the Obama administration's actions to combat antibiotic-resistant bacteria, and underscored two areas of critical importance."Antibiotic stewardship in healthcare settings is essential for fighting these life-threatening infections and reducing the significant cost associated with treating them," said Larry Mehren, CEO of Accelerate ...

Posted on: October 10, 2014
Study Confirms Superior Sensitivity of Digene HC2 HPV DNA Test vs. Other FDA-Approved Tests for HPV

A recently published study comparing three FDA-approved screening tests for human papillomavirus (HPV) provides the latest confirmation of superior sensitivity for QIAGEN's digene HC2 HPV DNA Test. HPV is the primary cause of cervical cancer, a cancer that can be deadly when the disease goes undetected and untreated.The study at Mayo Clinic compared the performance of FDA-approved HPV tests on 350 women with inconclusive or abnormal PAP (≥ ASC-US) using biopsy results as the reference ...

Posted on: October 09, 2014
BIOSTAT A Is New Entry-level Solution to Cell Culture and Microbial Fermentation

With its new BIOSTAT A, Sartorius Stedim Biotech presents a compact bioreactor/fermenter designed specifically as an entry-level model for fermentation and cell culture as well as for educational purposes. The system's control tower features a complete array of measurement and control functions like easy-load peristaltic pumps, an aeration module and conveniently accessible probe ports and supply connections. By virtue of its compact design, this new fermenter/bioreactor saves valuable space in a ...

Posted on: October 08, 2014
Study IDs Gene Network Behind Untreatable Leukemia and Possible Treatment Target

Researchers have identified a genetic/molecular network that fuels a high-risk and aggressive form of Acute Myeloid Leukemia (AML) and its precursor disease Myelodysplastic Syndrome (MDS) - providing a possible therapeutic strategy for an essentially untreatable form of the blood cancer.Scientists from the Cancer and Blood Diseases Institute (CBDI) at Cincinnati Children's Hospital Medical Center report their results in a study posted online Sept. 4 by Cell Reports.The specific forms of AML and MDS in the ...

Posted on: October 07, 2014
View Archives